BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32537434)

  • 1. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
    Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
    Front Oncol; 2020; 10():831. PubMed ID: 32537434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.
    Calabrò D; Argalia G; Ambrosini V
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Medicine and Radiological Imaging of Pancreatic Neuroendocrine Neoplasms: A Multidisciplinary Update.
    Prosperi D; Gentiloni Silveri G; Panzuto F; Faggiano A; Russo VM; Caruso D; Polici M; Lauri C; Filice A; Laghi A; Signore A
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portuguese Pancreatic Club Perspectives on Pancreatic Neuroendocrine Neoplasms: Diagnosis and Staging, Associated Genetic Syndromes and Particularities of Their Clinical Approach.
    Ferreira-Silva J; Meireles S; Falconi M; Fernandes A; Vilas-Boas F; Bispo M; Rio-Tinto R; Rodrigues-Pinto E;
    GE Port J Gastroenterol; 2024 Jun; 31(3):153-164. PubMed ID: 38836119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
    Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
    Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.
    Bevere M; Gkountakos A; Martelli FM; Scarpa A; Luchini C; Simbolo M
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
    Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
    Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current update on imaging for pancreatic neuroendocrine neoplasms.
    Segaran N; Devine C; Wang M; Ganeshan D
    World J Clin Oncol; 2021 Oct; 12(10):897-911. PubMed ID: 34733612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms.
    Palmieri LJ; Dermine S; Barré A; Dhooge M; Brezault C; Cottereau AS; Coriat R
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
    Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.
    Uccella S; Blank A; Maragliano R; Sessa F; Perren A; La Rosa S
    Endocr Pathol; 2017 Dec; 28(4):351-361. PubMed ID: 29063495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms.
    Mapelli P; Partelli S; Salgarello M; Doraku J; Muffatti F; Schiavo Lena M; Pasetto S; Bezzi C; Bettinardi V; Andreasi V; Rancoita PMV; Gianolli L; Picchio M; Falconi M
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
    April-Monn SL; Andreasi V; Schiavo Lena M; Sadowski MC; Kim-Fuchs C; Buri MC; Ketkar A; Maire R; Di Domenico A; Schrader J; Muffatti F; Doglioni C; Partelli S; Falconi M; Perren A; Marinoni I
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.
    Khanna L; Prasad SR; Sunnapwar A; Kondapaneni S; Dasyam A; Tammisetti VS; Salman U; Nazarullah A; Katabathina VS
    Radiographics; 2020; 40(5):1240-1262. PubMed ID: 32795239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
    Arakelyan J; Zohrabyan D; Philip PA
    Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.
    De Robertis R; D'Onofrio M; Zamboni G; Tinazzi Martini P; Gobbo S; Capelli P; Butturini G; Girelli R; Ortolani S; Cingarlini S; Pederzoli P; Scarpa A
    Neuroendocrinology; 2016; 103(6):758-70. PubMed ID: 26646652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
    de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
    J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
    Yang Z; Shi G
    Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
    J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.